Breast Cancer Trial, Not Yet Recruiting NCT07537712 Sponsor: Ruijin Hospital Condition: Breast Cancer
Back to Breast Cancer

Breast Cancer Trial, Not Yet Recruiting

NCT07537712
Not Yet Recruiting Not Applicable

voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice

Who may and may not be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who may be able to join

  • Women aged 18 or older.
  • People who have been diagnosed with invasive breast cancer or a type of early-stage breast cancer called ductal carcinoma in situ.
  • People who have had breast-conserving surgery (removal of the tumour while keeping most of the breast) or full breast removal, with or without an initial stage of breast reconstruction.
  • People with invasive breast cancer who had a procedure during surgery to check or remove lymph nodes in the armpit area.
  • People who have been advised to have radiation therapy after their breast surgery.
  • People whose general health and ability to function meets a minimum score on a standard medical assessment scale (confirm with trial site).
  • People whose life expectancy is estimated to be greater than 5 years.
  • People who are planned to receive a specific type of radiation therapy using either photon or proton beams, and who have provided written agreement to take part in the trial.

Who may not be able to join

Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.

  • People who have previously had radiation therapy to the chest area.
  • People with serious heart or lung problems, or other health conditions that mean radiation therapy is not considered safe for them.
  • People who are currently pregnant or breastfeeding.
  • People who currently have another active cancer diagnosis.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 30 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +86-021-64370045

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Not Yet Recruiting
Phase
Not Applicable
Sponsor
Registry
ClinicalTrials.gov
Start date
1 April 2026
Est. completion
1 December 2027

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Composite Toxicity Event

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 30 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov